• Home
  • Pipeline
  • Metabolic Diseases
  • Head and Neck Cancer
  • Scientific References
  • Publicity re Research Findings
  • Investors
  • Founders and Management
  • Contact Us
  • Home
  • Pipeline
  • Metabolic Diseases
  • Head and Neck Cancer
  • Scientific References
  • Publicity re Research Findings
  • Investors
  • Founders and Management
  • Contact Us
For your health!  Developing drugs for unmet medical needs.

Sveikatal's Pipeline

Sveikatal's development program can be divided into two areas:

  • Metabolic disorders,  including type 2 diabetes, liver disease, and hyperlipidemia
  • Cancer, with a focus on a therapy for head and neck cancer

Therapy for metabolic disorders is based on our discovery that drugs that activate a specific retinoid receptor reverse type 2 diabetes and treat a variety  of metabolic disorders, including fatty liver disease.

Therapy for head and neck cancer (oral cancer) builds on our discovery that treatment with a combination of two drugs that act on two different retinoid receptors reduces the occurrence of head and neck cancer.


About Sveikatal

Sveikatal, a biotechnology start-up company, seeks to exploit opportunities revealed by biomedical research to relieve suffering and to improve the quality of life of patients with diseases where adequate treatments have not yet been developed. We are seeking partners to work with us in this quest.

Sveikatal, Inc.

 431 East 85th

New York, NY, 10028

jawsveikatalinc@gmail.com

212 744 2640

About | Privacy Policy | Sitemap
Log in Log out | Edit
Close